Hangzhou DAC Biotechnology Announces a Collaboration and License Agreement with Janssen for the Development of Novel Antibody-Drug Conjugates
Hangzhou, China, June 1st, 2022 -- Hangzhou DAC Biotechnology Co., Ltd. (“DAC Biotechnology”) today announced a ...
More
